Company intelligence / Profile preview

Hubei Biomedical Industry Technology Research Institute

Hubei, China

Ownership: Private
Development stage: Other

Overview

The company is sponsoring or conducting a clinical trial to test a product or therapy intended to relieve inflammation and itching in corticosteroid-responsive skin conditions; no published efficacy data yet

Therapeutic areas: ImmunologyDermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Hubei Biomedical Industry Technology Research Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hubei Biomedical Industry Technology Research Institute.

Explore the full profile